CHRONIC CONDITIONS MANAGEMENT
Obstructive Sleep Apnea
Increasing detection of sleep apnea: a global imperative
Globally, the estimated prevalence of OSA, as defined by an apnoea–hypopnoea index (AHI) of ≥5 events·h−1, is nearly 1 billion individuals1
OSA is associated with poorer quality of life, increased cardiometabolic risk, more frequent motor vehicle collisions and greater, costlier use of the healthcare system1.
Zoom on the US
Addressing complications with precision and innovation
411 Billion
OSA is associated with poorer quality of life, increased cardiometabolic risk, more frequent motor vehicle collisions and greater and more costly use of the healthcare system1.
20%
We’re dedicated to helping you improve your chronic condition patient care
Discover our cutting-edge suite of connected health devices.
Whether you represent hospitals, health systems, physician groups, or FQHCs, we offer comprehensive solutions designed to meet your unique needs.
Withings RPM features best-in-class clinically validated cellular devices and an intuitive, easy to integrate platform, giving your care staff full control over patient monitoring and care intervention.
Elevate your health program with medical-grade devices
Discover how our medical-grade devices, has performed in clinical studies — and how it can elevate your health program.
Multi-night measurement for diagnosis and simplified monitoring of obstructive sleep apnoea
Are we getting enough sleep? Frequent irregular sleep found in an analysis of over 11 million nights of objective in-home sleep data
Learn how our partnerships improve health outcomes
Improving adherence to sleep apnea treatment – An innovative collaboration between Asten Santé and Withings Health Solutions
Analyzing 11.6 million nights of sleep led to research on night to night variability
Interested in partnering with Withings Health Solutions?
References
1. Thornton, C. S. et al. Impact of wait times for treatment on clinical outcomes in patients with obstructive sleep apnoea: protocol for a randomised controlled trial. ERJ Open Res. 8, 00068–02022 (2022).
2. National Sleep Foundation. National Sleep Foundation https://www.thensf.org/.
3. The Costs of Insufficient Sleep. https://www.rand.org/randeurope/research/projects/the-value-of-the-sleep-economy.html.
4. Lechat, B. et al. Multinight Prevalence, Variability, and Diagnostic Misclassification of Obstructive Sleep Apnea. Am. J. Respir. Crit. Care Med. 205, 563–569 (2022).
We take pride in operating with integrity, and obtaining and maintaining EC and REACH declarations are of the utmost importance to us. Compliance documents are available for download for each of our products.